Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Partial splenic embolization facilitates completion of interferon therapy in patients with chronic HCV infection and hypersplenism.

× No keyword cloud information.

9 in total

1. Long term follow-up for patients with liver cirrhosis after partial splenic embolization.

Authors: K Murata; K Shiraki; K Takase; T Nakano; Y Tameda
Journal: Hepatogastroenterology Date: 1996 Sep-Oct

Review 2. Splenomegaly, hypersplenism and coagulation abnormalities in liver disease.

Authors: P A McCormick; K M Murphy
Journal: Baillieres Best Pract Res Clin Gastroenterol Date: 2000-12

Review 3. Prevention of hepatitis C virus-related hepatocellular carcinoma.

Authors: E Jenny Heathcote
Journal: Gastroenterology Date: 2004-11 Impact factor: 22.682

4. Long-term hematological and biochemical effects of partial splenic embolization in hepatic cirrhosis.

Authors: Takashi Tajiri; Masahiko Onda; Hiroshi Yoshida; Yasuhiro Mamada; Nobuhiko Taniai; Tatsuo Kumazaki
Journal: Hepatogastroenterology Date: 2002 Sep-Oct

5. Role of elevated platelet-associated immunoglobulin G and hypersplenism in thrombocytopenia of chronic liver diseases.

Authors: Akira Sanjo; Jujin Satoi; Akihiro Ohnishi; Junko Maruno; Masayuki Fukata; Naoki Suzuki
Journal: J Gastroenterol Hepatol Date: 2003-06 Impact factor: 4.029

Review 6. Managing the hematologic side effects of antiviral therapy for chronic hepatitis C: anemia, neutropenia, and thrombocytopenia.

Authors: Janus P Ong; Zobair M Younossi
Journal: Cleve Clin J Med Date: 2004-05 Impact factor: 2.321

Review 7. [Overwhelming postsplenectomy infection].

Authors: Ruy Garcia Marques; Andy Petroianu
Journal: Arq Gastroenterol Date: 2003-10-06

8. Severe complications from partial splenic embolization in patients with liver failure.

Authors: I Vujic; J W Lauver
Journal: Br J Radiol Date: 1981-06 Impact factor: 3.039

Review 9. Epidemiology and clinical aspects on hepatitis C.

Authors: Makoto Higuchi; Eiji Tanaka; Kendo Kiyosawa
Journal: Jpn J Infect Dis Date: 2002-06 Impact factor: 1.362

9 in total

6 in total

1. Evaluation of the effect of partial splenic embolization on platelet values for liver cirrhosis patients with thrombocytopenia.

Authors: Chi-Ming Lee; Ting-Kai Leung; Hung-Jung Wang; Wei-Hsing Lee; Li-Kuo Shen; Jean-Dean Liu; Chun-Chao Chang; Ya-Yen Chen
Journal: World J Gastroenterol Date: 2007-01-28 Impact factor: 5.742

2. Laparoscopic splenectomy with peginterferon and ribavirin therapy for patients with hepatitis C virus cirrhosis and hypersplenism.

Authors: Tomohiko Akahoshi; Morimasa Tomikawa; Daisuke Korenaga; Koji Ikejiri; Motonori Saku; Kenji Takenaka
Journal: Surg Endosc Date: 2009-08-19 Impact factor: 4.584

3. Role of growth factors and thrombopoietic agents in the treatment of chronic hepatitis C.

Authors: Hans L Tillmann; Keyur Patel; John G McHutchison
Journal: Curr Gastroenterol Rep Date: 2009-02

4. Partial splenic embolization with transarterial chemoembolization in patients with hepatocellular carcinoma accompanied by thrombocytopenia.

Authors: Yoshihiko Ooka; Tetsuhiro Chiba; Sadahisa Ogasawara; Tenyu Motoyama; Eiichiro Suzuki; Akinobu Tawada; Fumihiko Kanai; Osamu Yokosuka
Journal: Biomed Res Int Date: 2014-09-15 Impact factor: 3.411

Review 5. Clinical application of partial splenic embolization.

Authors: Yong-Song Guan; Ying Hu
Journal: ScientificWorldJournal Date: 2014-11-03

6. Short-term Effects of Hepatic Arterial Buffer Responses Induced by Partial Splenic Embolization on the Hepatic Function of Patients with Cirrhosis According to the Child-Pugh Classification.

Authors: Tsuyoshi Ishikawa; Ryo Sasaki; Tatsuro Nishimura; Takashi Matsuda; Takuya Iwamoto; Issei Saeki; Isao Hidaka; Taro Takami; Isao Sakaida
Journal: Intern Med Date: 2020-12-07 Impact factor: 1.271

6 in total